EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated non-targeted and targeted metabolomics reveals tryptophan metabolism disorders in hypertension

Jing-Wen Yue, Yun-Feng Fang, Li Jiang, Tong-Shuai Wang, Zhen-Xian Zhang

Frontiers in Cardiovascular Medicine · 05.08.2026 · 13

DOI: 10.3389/fcvm.2026.1805381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 05.08.2026. Verfasst von Jing-Wen Yue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Medicine Department, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese …. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to characterize serum metabolic profiles in hypertensive patients and investigate the regulatory role of tryptophan metabolism.

Methods

We employed an integrated metabolomics strategy that combined non-targeted screening with targeted validation. From November 2022 to November 2023, we enrolled 25 newly diagnosed, treatment-naïve hypertensive patients and 25 age- and sex-matched healthy controls (1:1 ratio) from a local Shanghai hospital, together with their clinical baseline data. Non-targeted metabolomics, combined with Principal Component Analysis (PCA) and Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) were used to identify differential metabolic pathways. Subsequent targeted metabolomics analysis was conducted to quantify key molecules involved in the tryptophan metabolic pathway.

Results

Non-targeted metabolomics revealed 2,931 metabolites, with 759 showing differential expression (296 up-regulated and 463 down-regulated), emphasizing tryptophan metabolism as the central dysfunctional pathway. Targeted validation confirmed abnormalities in three branches of tryptophan metabolism: 5-hydroxytryptamine (5-HT) was down-regulated by 30% (Fold change = 0.69, P = 0.002), while five metabolites, such as 5-HT acid (Fold change = 1.33, P = 0.002) and kynurenine (Fold change = 1.35, P = 0.004), exhibited significant up-regulation (all P < 0.05). Network pharmacology analysis indicated strong binding affinities between tryptamine metabolites (Serotonin and L-5-Hydroxytryptophan), kynurenine metabolites (3-Hydroxykynurenine and Kynurenine), and indole metabolites (Hydroxyindoleacetic acid and Indolelactic acid) with their respective targets SLC6A4, KYNU, and SLC6A2.

Conclusion

Dysregulation of the tryptophan metabolic network-characterized by kynurenine pathway activation, 5-HT pathway inhibition, and microbial-indole pathway imbalance-is a key pathological mechanism in hypertension. These key molecules regulate targets such as SLC6A4, KYNU, and SLC6A2, potentially offering mechanistic insights for future precision intervention studies.

Schlagwörter

Stichwörter der Autor:innen

hypertensionkynurenine pathwaymetabolomicsnetwork pharmacologyserotonin pathwaytryptophan metabolism

Autor:innen und Institutionen

  • Traditional Medicine Department, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Institute of Cardiovascular Diseases, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Zitieren

APA

Yue, J. W., Fang, Y. F., Jiang, L., Wang, T. S., & Zhang, Z. X. (2026). Integrated non-targeted and targeted metabolomics reveals tryptophan metabolism disorders in hypertension. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1805381

Vancouver

Yue JW, Fang YF, Jiang L, Wang TS, Zhang ZX. Integrated non-targeted and targeted metabolomics reveals tryptophan metabolism disorders in hypertension. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1805381

BibTeX
@article{Yue2026,
  author = {Yue, Jing-Wen and Fang, Yun-Feng and Jiang, Li and Wang, Tong-Shuai and Zhang, Zhen-Xian},
  title = {Integrated non-targeted and targeted metabolomics reveals tryptophan metabolism disorders in hypertension},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1805381}
}
Kostenlos starten →